Is Lorlatinib Tablet (Lorbrena) in shortage?
Lorlatinib Tablet is listed by FDA as being discontinued by at least one maker (updated Jun 15, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03)
Supply expected to exhaust 6/30/2026; NDC 0069-0227-01 25 mg; 30 tablets bottle with a child-resistant closure will continue to be manufactured; Discontinuation of the manufacture of this presentation
Maker contact: 800-533-4535
Lorlatinib Tablet shortage questions
Is Lorlatinib Tablet (Lorbrena) in shortage?
Lorlatinib Tablet is listed by FDA as being discontinued by at least one maker (updated Jun 15, 2026).
What should I do if I can’t get Lorlatinib Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.